Valuation (62%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 25.02 | N/A |
| PEG Ratio (TTM) | -8.01 | N/A |
| P/S Ratio (TTM) | 2.76 | N/A |
| P/B Ratio (TTM) | 7.65 | N/A |
| P/FCF Ratio (TTM) | 17.39 | N/A |
| Price to 5YR AVG Earnings Ratio | 31.30 | N/A |
| Price to 5YR AVG FCF Ratio | 20.11 | N/A |
Profitability (85%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 17.78% | N/A |
| ROE (TTM) | 34.20% | N/A |
| Net Profit Margin (TTM) | 11.05% | N/A |
| ROIC 5YR AVG | 39.37% | N/A |
Growth (57%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -2.48% | 198.38% | 117.26% |
| Revenue | 1.35% | 0.00% | 1.27% |
| Net Income | -1.77% | 193.32% | 112.37% |
| Cash Flow | 134.09% | 13.31% | 6.10% |
Health (82%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.51 | N/A |
| Quick Ratio (TTM) | 1.51 | N/A |
| D/E Ratio (TTM) | 0.19 | N/A |
| Interest Coverage (TTM) | 24.30 | N/A |
| Piotroski F-Score | 8 | N/A |
| Altman Z-Score | 9.54 | N/A |
| LTL to 5YR AVG FCF | 0.79 | N/A |
| Shares Outstanding Growth 5YR AVG | -3.11% | N/A |